2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0 Purity ≥99.5% (GC) Sitagliptin Phosphate Monohydrate Intermediate

Whakaahuatanga Poto:

Ingoa matū: 2,4,5-Trifluorophenylacetic Acid

CAS: 209995-38-0

Parakore: ≥99.5% (GC)

Te ahua: Ma ki te Paura-White

Takawaenga o Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) mo te maimoatanga o te mate huka momo 2

Kounga Teitei, Hanganga Aromoni

E-Mail: alvin@ruifuchem.com

Tukuna he imeera ki a matou

Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Whakaratohia nga Kaiwaenga e Pa ana ki te Sitagliptin Phosphate Monohydrate:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Waikawa CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Wakawa Butyric CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Takawaenga CAS 486460-21-3

Nga Ahuatanga matū:

Ingoa matū	2,4,5-Trifluorophenylacetic Waikawa
Tau CAS	209995-38-0
Tau CAT	RF-PI1191
Tūnga Taonga	I roto i te Stock, Production Tauine Up ki Taranata
Tātai rāpoi	C8H5F3O2
Taumaha rāpoi	190.12
Te Whakarewa	121.0 ki te 125.0 ℃
Wairewa	Wairewa ki Methanol
Waitohu	Ruifu Chemical

Whakatakotoranga:

Tūemi	Whakatakotoranga
Te ahua	Ma ki te Paura-White
Te Maama / Tikanga Tatauria	≥99.5% (GC)
makuku (KF)	≤0.50%
Te toenga i runga i te mura	≤0.50%
Nga poke katoa	≤0.50%
Paerewa Whakamatau	Paerewa hinonga
Whakamahinga	Takawaenga o Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Cardboard Drum, kia rite ranei ki te hiahia a te kaihoko.

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku.

Painga:

FAQ:

Taupānga:

Ko te 2,4,5-Trifluorophenylacetic Acid (CAS: 209995-38-0) he takawaenga o Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9).Ka whakamahia te Sitagliptin Phosphate (STG) ki te rongoa i te momo DM 2 na te mea ka pai ake te whakahaere glycemic ma te whakanui ake i nga taumata o nga homoni incretin kaha, GLP-1 (peptide-1) me GIP (glucose-dependent insulinotropic peptide).Ko te whakahohenga o enei incretins i roto i nga pūtau β-pancreatic ka piki ake nga taumata o te cyclic adenosine monophosphate (cAMP) me te konupūmā i roto i te pūtau, me te tukunga o te insulin i muri mai ka whakawhirinaki ki te huka (2).Ko tenei raau taero hypoglycemic no te karaehe hou e kiia nei ko te dipeptidyl peptidase IV inhibitors.I whakamanahia a STG e te FDA i te tau 2006.